INTERVIEW

• From Treatment to Prevention, Top Expert on AD Research, Aducanumab and Its Implications - 2
  February 8, 2021

• Alzheimer’s Treatment at Crossroads? Top Expert on AD Research, Aducanumab and Its Implications - 1
  February 2, 2021

• Improper Materials Apparently Decreased after Promotion Guidelines Introduced: Pharmacist
  February 10, 2020

• “Excessive Self-Restraint” of Promotion Activities by Drug Makers Hindering Drugs’ Lifecycle Management: Physician
  January 28, 2020

• Causes of NDMA Contamination Scandal Still under Investigation: NIHS Division of Drugs
  January 27, 2020

• Pharma Industry Watered Down Original Proposals for Pricing Overhaul, Corrections Necessary: Kenporen Director
  September 12, 2019

• As New Era Dawns, Eisai CEO Says Pharma Could Be True Winner of 4th Industrial Revolution
  May 8, 2019

• Nichi-Iko to Leverage Synergies of Integration with Elmed Eisai: Sales Head
  April 22, 2019

• I’ve Done Everything I Can in 11 Years, Says Outgoing PMDA Chief
  March 28, 2019

• With HIV Back in Hand, Gilead Heading into Second Phase in Japan Market: Pres. Hermans
  March 26, 2019

• JMA Exec Matsumoto: CEA Scheme Merely a Supplemental Tool to Drug Pricing System, Continued Discussions Necessary
  March 7, 2019

• Interview: Pfizer Japan Looks to Offer High Quality Biosimilars with Go-It-Alone Strategy
  February 2, 2018

• Taiyo Pharma Eyeing 10 Trillion Yen Japanese Market, Looking to Use In-House Technologies to Develop New Products: COO
  January 10, 2018

• Chordia President Confident in Success of “Synthetic Lethality” Drug; Negotiated Directly with Takeda to Establish Startup
  December 7, 2017

• Takeda Eager to Build Life Science Hub in Shonan, Offer Research Environment Akin to US East Coast: Exec Hirate
  October 24, 2017

• Me Pharma Sees Opportunities in Low-Cost Strategy, Could Carve Out New Biz Models: President
  August 14, 2017

• Centerpiece of FPMAJ’s Lobbying Push Will Be Price Maintenance Premium: Chairman
  April 14, 2017

• Scohia Wants to Make Its “Carve Out” a Success Model for Japan Makers: CEO
  April 5, 2017

• Chugai to Execute Area-Based Strategy Centering on General Reps: Marketing Chief
  March 6, 2017

• Daiichi Sankyo Espha Eyes 50 Billion Yen Sales in 2020 with AGs as Growth Engine
  February 28, 2017

ページ